TXMD - TherapeuticsMD Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript

TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Conference Call March 2, 2021 08:30 ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer James D'Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitchell Krassan - Chief Strategy & Performance Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Annabel Samimy - Stifel Douglas Tsao - H.C. Wainwright Presentation Operator Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Fourth Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol. Nichol Ochsner Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth quarter financial results and business update. This morning, TherapeuticsMD issued a press release, announcing our fourth quarter financial results. The press release is available on

For further details see:

TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript